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AESTRACT. Fasted male rats were given single intraperitoneal injections of 
corticosterone or of saline. 
exd cell-sap protein was subsequently assayed using cell-free systems. 
enous pyruvate kinase and added phospho-enol pyruvate were used t o  maintain 
nucleotide triphosphate levels necessary fo r  prolonged incorporation. 
of 25 o r  50 pg/Kg were  effective i n  stimulating incorporation. 
Amino acid incorporation into l i ve r  microsomal 
Endog- 
Doses 
The latter 
dose signiTicantdy stimuiated microsomal incorporation 2 4  a t  15 min and 
118$ a t  30 min. 
part, this was attributed t o  feedback inhibition of the pi tui tary adrenal 
axis with a resultant decrease i n  endogenous corticosterone secretion. 
ulation w i t h  a wider range of doses was also seen i n  adreno-demedullated rats, 
thus largely excluding epinephrine as a factor. 
with stimulatory doses and subsequently tested i n  an incorporation system u t i l i z -  
ing added creatine kinase and creatine phosphate f o r  energy regeneration, no 
consistent stimulation of incorporation a t  15 or  30 min was observable. The 
res-dts suggest a rapid effect  of corticosterone on endogenous l i ve r  pyruvate 
Larger doses had no effect  a t  these time intervals. In  
Stim- 
When intact  rats were injected 
kinase activity.  
INTRODUCTION 
It is  well established that large o r  repeti t ive doses of glucocorticoids 
can lead to a stimulation of l iver  protein synthesis (1,2). A degree of spec- 
i f i c i t y  is demonstrated i n  t h i s  s thu la t ion  since stme enzymes concerned with 
gluconeogenesis are preferentially affected (2,3) . 
Recent studies directed toward an understanding of the primary action of 
th i s  class of hormones offer  evidence t o  support a number of views (2,4,5,6,7). 
Much of the previous work employed e i ther  massive doses of corticoids nut 
. 
necessarily natural t o  the experimental animal, o r  steroids altered so as t o  
prolong the i r  action (1,2,6,7). 
is t ra t ions give rise t o  changes not encountered by naturaUy induced elevations 
Geller -- e t  al. (8) has shown that such admin- 
i n  endogenous corticosteroid levels. Corticosterone i s  the predominant gluco- 
corticoid i n  the rat (9). Therefore, it seemed appropriate to study its effect  
on subsequent i n  v i t ro  protein synthesis when administered i n  vivo i n  quantities 
M A " S  AND METHODS 
Male Sprague-Dawley rats were obtained frm Simonsen Farms, G i l r o y ,  California, 
The weights  ranged between 220-290 g (7 t o  9 weeks old). 
6 weeks old were obtained from the same source 3 weeks pr ior  t o  experimentation. 
Histologic sections of the adrenal glands frm these rats showed no evidence of 
z e & i l l a r y  tissue. 
f ac i l i t i e s  with a 6 AM t o  6 PM daylight cycle. 
Adreno-demedullated rats 
All animals were maintained on Puriaa Laboratory Chow i n  
The animals were weighed and fasted 18 hours pr ior  t o  injection and this 
weight used t o  calculate the dose. The corticosterone was suspended i n  saline 
Sy hcmogenization, usually at a concentration of 50 pg/ml. 
diurnal effect  (lo), injections were ini t ia ted between 9 AM and ll AM. 
Injections w e r e  done without noticeably exciting the animals. 
To minimize the 
Controls 
were injected w i t h  saline. The animals were treated and processed a t  3-min 
intervals, usually i n  groups of 8. 
bled for  10 sec. 
mitochondrial supernatants were prepared i n  a manner pkviously described 
(1,ll). The medium had a final concentration of O.O25M KC1, 0.03M MgC12, 
0.035M Tris buffer (pH 7.8) and 0.25M sucrose. 
They were sacrificed by decapitation and 
The excised l ivers were rinsed and homogenized, and post- 
For the incubation, each 
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K # 
tube contained 20 pmoles of tricyclohexylammonium PEP,2 2 p o l e s  disodium ATP, 
. 0.4 poles disodium GTP, 0.1 pmoles ~a l ine- l - '~C (0.588 pc) and 1.4 m l  of post- 
mitochondrial supernatant. 
w i t h  KC1 i n  a final volume of 2.3 m l .  
The potassium concentration was adjusted t o  150 mM 
I n  some experiments ("able l), the 
~ a l i n e - l - ~ ~ c  bad an act ivi ty  of 0.625 pc in  0.03 pmoles. 
When creatine phosphate was used t o  regenerate nucleotide triphosphate, 
20 p d e s  of i~isodhiia ereatiiie phosphate an6 2~ pg (4 enzyme uni t s j  of creatine 
kinase per tube were substituted f o r  the PEP. 
The incubation period was 10 minutes a t  37 C. The reaction was stopped by 
placing the tubes i n  an ice bath and by diluting with cold medium. 
and c e l l  sap were separated by centrifugation; each fraction was precipitated 
and extracted and the protein residue was pressed onto copper planchets having 
a diameter of 0.85 cm (1,ll). They were counted i n  a Tracerlab Omni-Guard l o w  
bac'kground gas flow counter. 
use of a 14C methacrylate standard for  calibration and by employment of the 
e q a t i o n s  f o r  self-absorption corrections suggested by Murarnatsu a d  Busch (12) . 
Sufficient counts were taken t o  ensure less than 4$ counting error with the ce l l -  
sap protein and less  than 2$ counting error with the microscanal proteins. 
lYicrosomes 
Activity was expressed as dpm/mg of protein by 
Corticosterone was estimated on plasma obtained from heparinized blood 
collected a t  the time of decapitation. 
for the determinations (13). 
plasma fluorescence which averaged 10.6 pg/lOO m l  of plasma as determined on 
adrenalectomized rats. 
A microfluorometric method was employed 
The values reported are uncorrected far residual 
Valine-1-14C was obtained from New England Nuclear Corporation, Walt-, 
Massachusetts. 
Biochem, Los Angeles, California. 
All other biochemicals and enzymes were obtained from C a l  
. 
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Alterations i n  Amino Acid Incorporation. I n  preliminary experiments it 
was found that  25 or 50 pg/Kg of corticosterone would stimulate incorporation 
within 15 to 30 min relative t o  saline-injected controls. A f t e r  1 hr  a stim- 
ulation was not observed. Larger doses were ineffective a t  these time periods. 
The results with pyruvate kinase-dependent systems prepared 30 min follow- 
ing the injection of e i ther  saline or corticosterone are sham in Mg. 1. A 
one-way analysis of variance of the 7 groups indicated a significant difference i n  
the means (p < 0.025). 
(14), it was found tha t  the group dose of 50 pg/Kg was significantly different 
from that of the saline-injected g r o q  (p < 0.05). 
In  particular, using Scheffe's method of camparison 
No other significant con- 
trasts were found. 
Incorporation i n  Adreno-Demedullated R a t  Preparations. The use of saline- 
injected controls largely eliminates epinephrine as a factor i n  the changes i n  
amino acid incorporation sham i n  Fig. 1. Nevertheless, since t h i s  hormone is 
also reported to  affect  the rate of l iver  protein synthesis (15), i t s  possible 
involvement was further tested by making use of adreno-demedullated rats .  
Amino acid incorporation was tested 30 m i n  following the injection of 
saline or of corticosterone i n  doses ranging from 25 to 250 pg/Kg. The results 
are. i l lustrated i n  Fig. 2. Incorporation into microsomal protein was s igni f i -  
cantly elevated a t  a l l  dose levels tested. A two-way analysis of variance was 
performed on microsomes, with dosage and blocks (experiment number) as the two 
factors. It was found that  the dose response was significantly greater (p < 0.025) 
than the control group fo r  a l l  levels of doses. No significant differences between 
dose levels were found. A similar analysis of cell-sap response shared no statis- 
t i ca l ly  significant changes. With both in tac t  and adreno-demeddlated rats, 
however, the parallelism between microsomal and cell-sap incorporation rates is 
nevertheless apparent. 
- 
4 --- 
i 
Involvement of the Ebergy Regeneration System. In the experiments so far 
described, continued incorporation was fac i l i t a ted  by using endogenous pyruvate 
kinase t o  regenerate nucleotide triphosphates from added phospho-enol pyruvate. 
Tnerefore, the observed changes could be due to alterations i n  the ac t iv i ty  of 
t h i s  enzyme through i ts  capacity to  maintain the energy level  of the system. 
This possibil i ty was tested by simultaneously comparing incorporation from saline- 
and corticosterone-injected r a t s  with both the above system and one which depends 
on added creatine phosphate and creatine kinase fo r  optimal activity.  
In preliminary experiments it was found that 2 to  4 enzyme units of creatine 
kinase caused optimal act ivi ty  when the PEP was replaced by an equivalent amount 
of creatine phosphate. 
a comparable PEP-dependent system; yet the creatine phosphate system is capable 
of accommodating even greater rates of incorporation, for  example, when l ive r  
preparations from fed rats o r  from stress-stimulated rats are employed (11). 
Therefore, the ra te  of nucleotide triphosphate regeneration is not the limiting 
factor i n  th i s  creatine phosphate-dependent system, whereas th i s  could be the 
csse when incorporation is dependent on endogenous pyruvate kinase levels. 
I: zz ckcre,-i-i-C s-tfrm?TEtion -3y corzicusterone Ls d!ue to Pdm oI5ier th9n: a m u r e  
eff ic ient  energy regeneration, both systems should shuw the increase. 
The level of incorporation is considerably higher than i n  
Thus, 
- .  
Such a comparison of preparations obtained 15 min after the i n  vivo injec- -- 
t ion of e i ther  saline or of 50 pg/Kg of corticosterone is shown i n  Table 1. 
The comparison shows that corticosterone significantly stimulates incorporation 
into microsomal protein i n  the pyruvate kinase system by about 2 4  (p < 0.05), 
whereas i n  the creatine kinase system no appreciable change is detected. 
both cases cell-sap incorporation is stimulated, but i n  neither case is it 
s t a t i s t i ca l ly  significant. 
t o  show a stimulation a t  30 min with the creatine kinase system. 
In 
In experiments not shown here it was not possible 
- 
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Changes in  Plasma Corticosterone. With the aim of relating the afore- 
mentioned changes in  amino acid incorporation to alterations i n  plasma 
corticosterone levels, such determinations were made on plasma obtained 0.5 hr 
following the injection of the various doses. These data, recorded i n  F i g .  3, 
show that only doses of lo00 pg/Kg or greater resul t  i n  plasma elevations 
significantly greater (p < 0.001) than the saline-injected controls. With the 
SX&% but f i O I i ~ k T f l L X k i %  increase WErS Ob6t?I?red. ~ A L c ~ - ~ , A v c  -*-I--..&<--.. U U ~ C  3--- of 50 @/Q, 
Unexpectedly, intermediate doses caused depressed plasma levels. Thus, a t  a 
dose of 200 pg/%, plasma corticosterone levels are approximately 1.2 pg$ lower 
than a t  a dose of 50 pg/Kg, 
nomenon since significant increases with these doses occur 8 min following 
the i r  injection.. 
This effect  appears t o  be due to a rebound phe- 
It should also be pointed out that i n i t i a l  plasma levels here, being on 
the order of k2 &, are somewhat higher than those &ported by others (16); 
however, i n  the present work f a s t e d  rats were employed. Determinations made 
with fed rats gave values compatible with the previously reported figures. 
This  elevated fasting level, nevertheless, probably serves to make any tend- 
ency t o  rebound more evident. 
Changes i n  plasma corticosterone levels a t  times following the injection 
of a s e t  dose of 50 pg/Kg or of saline w e r e  a lso evaluated. 
shown i n  Fig. 4. 
showed a significant difference i n  the means (p < 0.001). 
15 min following the injection, the corticosterone-injected group showed a 
significant r i s e  above both the saline-injected controls and the noninjected 
group (p < 0.05). The tendency t o  rebound for  both Injected groups was also 
noted here but was delayed samewhat. 
The results are 
A one-way analysis of variance performed on these data 
I n  particular, 
. 
DISCUSSION 
Interpretation of the amino acid incorporation data, t o  a large extent, 
depends on a knowledge of the plasma changes i n  corticosterone subsequent t o  
its injection. 
are controlled by a negative feedback system; and the changes described i n  
A considerable amount of evidence indicates that these levels 
Figs. 3 and 4 are  compatible with this  contention (17 ) . For example, it is 
known that  ACTH release is  inhibited by increased plasma levels of numerous 
corticoids. Such an action by corticosterone is an expl ic i t  requirement if 
i t s  plasma level  is t o  be controlled by such a system (17,18). Also, since 
circulating corticosterone has a rather short half-l ife,  being on the order 
of 15-25 min ( lg) ,  it is probable that above a certain threshold, the rapid 
r i s e  i n  plasma'levels subsequent t o  i t s  administration could so depress the 
release of ACTH, and consequently endogenous corticosterone production, that 
the decay process would momentarily predominate. 
larger doses of corticosterone are  administered, the amounts given could be 
sufficiently large t o  counter the decay process for  extended periods. 
On the other hand, when 
Thus, Harding -- e t  al .  (20) suggested tha t  the inhibition of liver alanine 
transaminase by the mineralo-corticoid, deoxycorticosterone is caused by such 
a suppressive action on AC'I" release. 
by adrenal gluco-corticoids; however, they found that deoxycorticosterone 
was Without effect  i n  hypophysectomized rats, nor did it prevent increases 
i n  ac t iv i ty  induced by ACTH administration to such rats. Likewise, it was 
found that a nuIiiber of corticoids including deoxycorticosterone generally 
had a depressant effect  on amino acid incorporation into liver systems 
subsequent t o  the i n  vivo injection of an intermediate range of doses (1). 
Ordinarily t h i s  enzyme is  maintained 
- I  
> .  
* 
t o  a stjmulation of pyruvate -kinase-dependent amino acid incorporation above 
Thus, it would seem that modest increases i n  plasma corticosterone can lead 
’ the basal level. Larger unphysiologic amounts neither stimulate nor depress 
incorporation significantly for the time intervals studied here. The reasons 
for t h i s  are not ent i re ly  clear. 
The stimulation occurs 15 min a f t e r  corticosterone injection. Shorter 
in+-erE%ls vere E& +psteCt= Acreszf!ir?g tG %he mrk of Hsdges -Toiles (16)) 
! 
peak plasma levels of corticosterone injected i n  a fashion similar t o  tha t  
employed i n  the present work occur a t  about 7 min. Therefore, the effect  of 
t h i s  corticoid on pyruvate-kinase-dependent incorporation would appear t o  be 
i rather direct  and rapid. The fac t  that stimulation is  s t i l l  evident 30 m i n  
i 
i 
a f t e r  injection when plasma levels are  normal or  nearly so is not contradictory 
t o  this idea since t issue levels may s t i l l  be elevated. 
Whether the first action of corticosterbne i s  on pre-existing p p v a t e  
kinase o r  whether it acts  by some other means cannot be stated on the basis 
of  2resently available information since early changes i n  messenger RNA have 
been reported with massive doses of cortisol, and it is possible that cortico- 
sterone might have a similar action ( 6 ) .  However, the data as presented here 
would give more credence t o  an activation. 
Nonetheless, it is interesting tha t  present concepts concerned with the 
gluconeogenic ac t iv i ty  of gluco-corticoids give great importance t o  the 
formation of phospho-enol pyruvate from lactate  and pyruvate (21). 
th i s  i s  controlled, i n  part, through the action of p;ynnrate carboxylase which 
i s  activated by acetyl coenzyme A (22). Thus, one possibi l i ty  considered by 
others (21,22,23) is tha t  within the structured order of the ce l l ,  increased 
pyruvate kinase ac t iv i ty  could lead t o  increasedlevels of acetyl coenzyme A 
and thereby stimulate the process of gluconeogenesis. 
Presumably, 
- 0 -  
i 
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TABLE 1. 
subsequent t o  i n  vivo injection of 50 pg/Kg of cort i -  
costerone or of saline vehicle. Anhals w e r e  simul- 
taneously tested i n  two differing incorporation 
systems. In  one case, PEP and endogenous pyruvate 
kinase were used. In the other, incorporation was 
dependent on added creatine kinase and creatine phos- 
phate. 
i n  0.037 pmoles . Values are given as i n  Fig. 1. 
I n  v i t ro  amino acid incorporation 15 min 
The 1-14c valine had an a c t i d t y  of 0.625 pc 
Each group consisted of 8 animals. 
~ 
Saline Corticosterone P 
?KF microsomes 15 47279 18461t91 < 0.05 
Creatine phosphate 25032121 2579225 Ns 
microsomes 
Creatine phosphate 226213 3m32 Ns 
c e l l  sap 
- 10 - 
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'Portions of this paper were presented at  the 49th Annual Meeting of the 
Federation of American Societies for  Experimental Biology, A t l a n t i c  City, 
New Jersey, April 13, 1965. 
2Abbreviations : PEP, phospho-enol pJrruvate; pH).m, tricyClobeXy1 
ammonium salt. 
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FIG. 1. 
prepared 30 min subsequent t o  the i n  vivo injection of various doses of cortico- 
stemae or saline. 
was exployed. (See methods. ) Abscissa: dose of corticosterone. Broken line: 
microsad .  protein specific act ivi ty  with values on le f t  ordinate. Solld line: 
cell-sap protein specific act ivi ty  with values on r ight  ordinate. The number of 
animals tested at  each point i s  shown i n  brackets. 
FIG. 2. 
prepared 30 min subsequent t o  w e c t i n g  adreno-demedullated rats with various doses 
Incorporation of 1-14c m i n e  into protein by cell-free rat l i ve r  systems 
-- 
A PEP.TCH4 s y s k a  using 0.588 pc in 0.1 mole of l-14C valine 
Standard errors are indicated. 
Incorporation of 1-14c valine into protein by cell-free rat l ive r  systems 
of corticosterone. 
are as indicated in Fig. 1. 
Eight ax&mls were used at  each point. A l l  other conditions 
F I G .  3. 
intraperitoneal injection of various doses. Abscissa: injected dose i n  pg/Kg. 
Ordinate: 
fluorescence. 
FIG. 4. 
peritoneal injection of 50 p g / ~  of corticosterone or 0.5 m l  of saline vehicle. 
Zero time represents noninjected animala. Abscisea: Sempllng t h e  subsequent 
t o  injection. ordinate: pla~ma level in pg/100 IUI, m r  of indicated 
in brackets. . 
Plasma corticosterone levels from blood obtained 30 m i n  following the  
plasma level  in ~g/lOO m l .  Values are uncorrected for  background 
Other conditions as i n  Fig, 1. Number of animals indicated i n  brackets. 
Plasma corticosterone levels at  time intervals following the intra-  
I 
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